Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

June 30, 2006

Conditions
Huntington's Disease
Interventions
DRUG

sodium phenylbutyrate

Trial Locations (8)

Unknown

University of Alabama, Birmingham

University of California-San Diego, San Diego

University of Iowa Hospital and Clinics, Iowa City

University of Kansas Medical Center, Kansas City

Johns Hopkins University, Baltimore

Massachusetts General Hospital, Boston

Columbia University, New York

University of Rochester, Rochester

Sponsors
All Listed Sponsors
collaborator

HP Therapeutics Foundation

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Columbia University

OTHER

collaborator

University of Iowa

OTHER

collaborator

University of California, San Diego

OTHER

collaborator

University of Kansas

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

Johns Hopkins University

OTHER

lead

University of Rochester

OTHER